The cell proliferation of human MLL leukemia cell lines (MV-4-11 and MOLM13) can be inhibited by MI-538, with two various MLL translocations (MLL-AF4 and MLL-AF9, respectively). This evidence concerns the gene KMT2A and leukemia.